Ticker League

EBITDA for Baxter International (BAX)

Latest filings through · Reported

Metric

TTM

$738.00M

YoY change

-31.4%

5Y CAGR

-19.5%

Peak year (2016)

$5.84B

EBITDA history chart for Baxter International (BAX) from 1985 to 2025

Latest: $766.00M

EBITDA growth chart for Baxter International (BAX) from 1985 to 2025

Latest: -31.4%

EBITDA history table for Baxter International (BAX) from 1985 to 2025

  • 2025$766.00M-31.4%
  • 2024$1.12B-35.6%
  • 2023$1.73B-198.4%
  • 2022−$1.76B-180.5%
  • 2021$2.19B-3.4%
  • 2020$2.27B+21.3%
  • 2019$1.87B-24.6%
  • 2018$2.48B+28.2%
  • 2017$1.94B-66.9%
  • 2016$5.84B+338.3%
  • 2015$1.33B-8.0%
  • 2014$1.45B+24.4%
  • 2013$1.17B-68.2%
  • 2012$3.66B+2.6%
  • 2011$3.57B+32.8%
  • 2010$2.69B-22.9%
  • 2009$3.49B+7.7%
  • 2008$3.24B+15.0%
  • 2007$2.82B+16.7%
  • 2006$2.42B+14.5%
  • 2005$2.11B+3.5%
  • 2004$2.04B-4.7%
  • 2003$2.14B-0.8%
  • 2002$2.16B+11.8%
  • 2001$1.93B+12.6%
  • 2000$1.71B+12.6%
  • 1999$1.52B+12.0%
  • 1998$1.36B+12.8%
  • 1997$1.21B-4.3%
  • 1996$1.26B+9.5%
  • 1995$1.15B-25.7%
  • 1994$1.55B+111.1%
  • 1993$733.00M-50.9%
  • 1992$1.49B-1.5%
  • 1991$1.51B+103.4%
  • 1990$745.00M-38.0%
  • 1989$1.20B+11.3%
  • 1988$1.08B+7.4%
  • 1987$1.01B+31.0%
  • 1986$768.00M+92.5%
  • 1985$399.00M—

EBITDA values are taken from Baxter International's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Baxter International (BAX)

According to Baxter International's latest reported financial statements, the company's current EBITDA (TTM) is $738.00M. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Baxter International (BAX) EBITDA is $766.00M – plunged 31.4% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Baxter International EBITDA compounded at -19.5% per year, with a net decline across the window.

Between 2016 and 2025, Baxter International EBITDA plunged 86.9%, falling from $5.84B to $766.00M.

The highest annual EBITDA of $5.84B was reported in 2016. The lowest in the available history was −$1.76B in 2022.

Baxter International EBITDA by Year

Baxter International EBITDA 2025: $766.00M

Baxter International EBITDA in 2025 was $766.00M, plunged 31.4% below 2024.

Baxter International EBITDA 2024: $1.12B

2024's EBITDA for Baxter International came in at $1.12B, plunged 35.6% below 2023.

Baxter International EBITDA 2023: $1.73B

Baxter International posted EBITDA of $1.73B in 2023, plunged 198.4% below 2022.

Baxter International EBITDA 2022: −$1.76B

In 2022, Baxter International reported EBITDA of −$1.76B, plunged 180.5% below 2021. This figure represents the lowest annual value in the available history.

Baxter International EBITDA 2021: $2.19B

Baxter International EBITDA in 2021 was $2.19B.

See more financial history for Baxter International (BAX).

Sector peers by EBITDA

Healthcare peers of Baxter International (BAX), ranked by their latest EBITDA

Frequently asked questions

Baxter International (BAX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview